Banfalvi G
Int J Mol Sci. 2022; 23(16).
PMID: 36012767
PMC: 9409004.
DOI: 10.3390/ijms23169503.
Yamashita S, Tanaka M, Ida C, Kouyama K, Nakae S, Matsuki T
Exp Cell Res. 2022; 417(1):113163.
PMID: 35447104
PMC: 10009817.
DOI: 10.1016/j.yexcr.2022.113163.
Curtin N
Cancers (Basel). 2020; 12(3).
PMID: 32121331
PMC: 7139537.
DOI: 10.3390/cancers12030564.
Turner R, Wilkinson J, Ornelles D
Virology. 2014; 456-457:205-19.
PMID: 24889240
PMC: 4044614.
DOI: 10.1016/j.virol.2014.03.010.
Klocker H, Auer B, Hirsch-Kauffmann M, Altmann H, Burtscher H, Schweiger M
EMBO J. 1983; 2(3):303-7.
PMID: 11894942
PMC: 555133.
DOI: 10.1002/j.1460-2075.1983.tb01423.x.
Differential effects of the poly (ADP-ribose) polymerase (PARP) inhibitor NU1025 on topoisomerase I and II inhibitor cytotoxicity in L1210 cells in vitro.
Bowman K, Newell D, Calvert A, Curtin N
Br J Cancer. 2001; 84(1):106-12.
PMID: 11139322
PMC: 2363607.
DOI: 10.1054/bjoc.2000.1555.
Low nicotinamide mononucleotide adenylyltransferase activity in a tiazofurin-resistant cell line: effects on NAD metabolism and DNA repair.
Boulton S, Kyle S, Durkacz B
Br J Cancer. 1997; 76(7):845-51.
PMID: 9328141
PMC: 2228057.
DOI: 10.1038/bjc.1997.473.
Potentiation of temozolomide-induced cytotoxicity: a comparative study of the biological effects of poly(ADP-ribose) polymerase inhibitors.
Boulton S, Pemberton L, Porteous J, Curtin N, Griffin R, Golding B
Br J Cancer. 1995; 72(4):849-56.
PMID: 7547230
PMC: 2034052.
DOI: 10.1038/bjc.1995.423.
Activation of ADP-ribosyltransferase in polyamine-depleted mammalian cells.
Wallace H, Gordon A, Keir H, Pearson C
Biochem J. 1984; 219(1):211-21.
PMID: 6326755
PMC: 1153467.
DOI: 10.1042/bj2190211.
Polyoma virus minichromosomes: poly ADP-ribosylation of associated chromatin proteins.
Gourlie B, Miwa M, Pigiet V, Sugimura T, Malik N, Smulson M
J Virol. 1983; 45(2):600-6.
PMID: 6300423
PMC: 256454.
DOI: 10.1128/JVI.45.2.600-606.1983.
Evidence that poly(ADP-ribose) polymerase is involved in the loss of NAD from cultured rat liver cells.
Paine A, Allen C, Durkacz B, Shall S
Biochem J. 1982; 202(2):551-3.
PMID: 6284133
PMC: 1158142.
DOI: 10.1042/bj2020551.
NAD+, ADP-ribosylation and transcription in permeabilized mammalian cells.
Walker J, Pearson C
Biochem J. 1981; 199(3):813-7.
PMID: 6280677
PMC: 1163440.
DOI: 10.1042/bj1990813.
Mono- and poly-ADP-ribosylation of proteins in mouse kidney after castration and testosterone treatment.
Gartemann A, Bredehorst R, Wielckens K, Stratling W, Hilz H
Biochem J. 1981; 198(1):37-44.
PMID: 6275842
PMC: 1163208.
DOI: 10.1042/bj1980037.
Hormonal stimulation of eucaryotic cell ADP-ribosylation.
Filetti S, Rapoport B
J Clin Invest. 1981; 68(2):461-7.
PMID: 6267105
PMC: 370819.
DOI: 10.1172/jci110276.
Antitumour imidazotetrazines--XI: Effect of 8-carbamoyl-3-methylimidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one [CCRG 81045; M and B 39831 NSC 362856] on poly(ADP-ribose) metabolism.
Tisdale M
Br J Cancer. 1985; 52(5):789-92.
PMID: 3864485
PMC: 1977218.
DOI: 10.1038/bjc.1985.259.
At least 60 ADP-ribosylated variant histones are present in nuclei from dimethylsulfate-treated and untreated cells.
Boulikas T
EMBO J. 1988; 7(1):57-67.
PMID: 3359995
PMC: 454215.
DOI: 10.1002/j.1460-2075.1988.tb02783.x.
Eukaryotic nuclear ADP-ribosylation reactions.
Gaal J, Pearson C
Biochem J. 1985; 230(1):1-18.
PMID: 2996490
PMC: 1152580.
DOI: 10.1042/bj2300001.
Some early events in the primary mitogenic stimulation of lymphocytes differ from later interleukin stimulation and other quiescence to growth activation systems.
Johnstone A, Darling D
Immunology. 1985; 55(4):685-92.
PMID: 2991130
PMC: 1453789.
